We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Experts warn of bots manipulating the news agenda, social media and elections as well as the hijacking of drones and autonomous vehicles.
Opponents have accused May of being 'too weak' to face down hard Brexiteers after more than 60 MPs set out their demands for EU exit talks.
Sadly, these high-school students have already received the most abrupt and cynical lesson of their lives.